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Abstract
The etiology of sporadic Alzheimer disease (AD) is largely unknown, although evidence implicates the pathological hallmark
molecules amyloid beta (Ab) and phosphorylated Tau. Work in animal models suggests that altered axonal transport caused
by Kinesin-1 dysfunction perturbs levels of both Ab and phosphorylated Tau in neural tissues, but the relevance of Kinesin-1
dependent functions to the human disease is unknown. To begin to address this issue, we generated human embryonic
stem cells (hESC) expressing reduced levels of the kinesin light chain 1 (KLC1) Kinesin-1 subunit to use as a source of human
neural cultures. Despite reduction of KLC1, undifferentiated hESC exhibited apparently normal colony morphology and
pluripotency marker expression. Differentiated neural cultures derived from KLC1-suppressed hESC contained neural
rosettes but further differentiation revealed obvious morphological changes along with reduced levels of microtubule-
associated neural proteins, including Tau and less secreted Ab, supporting the previously established connection between
KLC1, Tau and Ab. Intriguingly, KLC1-suppressed neural precursors (NPs), isolated using a cell surface marker signature
known to identify cells that give rise to neurons and glia, unlike control cells, failed to proliferate. We suggest that KLC1 is
required for normal human neural differentiation, ensuring proper metabolism of AD-associated molecules APP and Tau
and for proliferation of NPs. Because impaired APP metabolism is linked to AD, this human cell culture model system will
not only be a useful tool for understanding the role of KLC1 in regulating the production, transport and turnover of APP and
Tau in neurons, but also in defining the essential function(s) of KLC1 in NPs and their progeny. This knowledge should have
important implications for human neurodevelopmental and neurodegenerative diseases.
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Introduction
Normal cellular organization and function requires intracellular
transport driven by molecular motors. Kinesin-1 is a microtubule-
based motor, moving cargos towards the plus end of microtubules
[1,2] in neurons and in other cell types. Kinesin-1 is composed of a
pair of heavy chains (KHCs), which use ATP hydrolysis to power
movement on microtubules, and a pair of light chains (KLCs),
which regulate KHC activity and mediate cargo attachment [3].
Mammalian Kinesin-1 is assembled from three KHC gene
products - Kinesin-1A, -1B or 1C (formerly KIF5A, KIF5B or
KIF5C, respectively) and four KLCs (KLC1, KLC2, KLC3, or
KLC4) [4–8].
In mice, Kinesin-1 subunits have tissue specific expression
patterns: Kinesin-1B and KLC2 are ubiquitously expressed while
Kinesin-1A, Kinesin-1C and KLC1 are enriched in neural tissue
[7–10]. As revealed by animal studies in which various subunits
are altered, Kinesin-1 plays important roles in the nervous system.
For instance, Kinesin-1C and KLC1 mutant mice exhibit
reductions in brain size and/or white matter tracts [9,11] and
cultured primary neurons with reduced Kinesin-1B, Kinesin-1C
or KLC1 subunits have shorter neurites [12–14]. Kinesin-1A,
Kinesin-1C and KLC1 mouse mutants exhibit loss of specific
neuron populations [9,11,15]. Further, mutations in fruit fly KHC,
KLC or mouse Kinesin-1A or KLC1 lead to axonal transport
defects [15–18]. These observations suggest that specific Kinesin-1
subunits may have multiple functions in the nervous system.
Kinesin-1 is a major anterograde motor driving transport into
the axons of neurons and faulty axonal transport may contribute
to neurodegenerative diseases [19]. Alzheimer’s disease (AD) is
characterized pathologically by the presence of brain amyloid
plaques and neurofibrillary tangles, the principle components of
which are the amyloid precursor protein (APP) proteolytic
cleavage product Ab and the axonal microtubule associated
protein Tau. APP is transported to synapses in a Kinesin-1
dependent manner and associates closely with KLC [20–23]. Tau
also interacts with KLC1 and may be transported in the axon by
Kinesin-1 [24]. KLC1 mutant mice have hyperphophorylated
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function exhibit earlier and accentuated brain amyloid plaques,
thought to be caused by abnormal APP transport and/or cleavage
[26]. Together these data lead us to suggest that KLC1 can
modulate APP and Tau function but this is challenging to test in
human neurons.
Progress in understanding human development and disease is
limited by a lack of appropriate human model systems. While
model organisms and human immortalized cells will continue to
provide useful information, species or cell type differences restrict
their utility. Human embryonic stem cells (hESC) [27] offer
important benefits for modeling human development and disease
[28,29]. Not only are hESC a potential source of all human cell
types, including neural precursors (NPs) and neurons, but they also
proliferate indefinitely in culture, are genetically malleable, and
express proteins under endogenous transcriptional, translational
and post-translational control. Thus, we used hESC as a source of
neural cells to probe human neural development and possible roles
of transport in neurodegenerative disease pathways in AD. In this
study we engineered hESC to express reduced levels of KLC1
using small hairpin RNA (shRNA) targeted to KLC1 and
examined whether suppression of endogenous KLC1 impairs
human neural differentiation or endogenous human APP
metabolism, which is implicated in AD.
Materials and Methods
Cell culture and subcloning of undifferentiated Hues9
hESC lines
DNA oligonucleotides targeting KLC1 exon 2 (Forward 59-
TGTAATTTGGTGGAGGAGAATTCAAGAGATTCTCCT-
CCACCAAATTACTTTTTTC-39 and Reverse 59-TCGAGA-
AAAAAGTAATTTGGTGGAGGAGAATCTCTTGAATTCT-
CCTCCACCAAATTACA -39were subcloned as described [30]
into pSicoR, or a modified pSico derived plasmid lacking the
CMV-GFP cassette (Figure S1A). Vesicular stomatitis virus G
protein pseudotyped lentivirus was prepared at the University of
California, San Diego Vector Development lab to a titer of 10
8
colony forming units/ml.
Undifferentiated Hues9 hESC lines were maintained as
described [31]. To derive Hues9 lines with reduced KLC1 Hues9
were exposed to lentivirus encoding KLC1 shRNA and plated at
limiting dilution. Single hESC colonies were expanded and viral
insertion confirmed by PCR. Cells were karyotyped by Cell Line
Genetics (Madison, WI) (Figure S1B).
Neural differentiation
For differentiating hESC using the embryoid body (EB) method
[32], confluent cultures of shKLC1-1, shKLC1-2 and uninfected
parental control hESC were dispase treated (BD; 1:50 in hESC
media), scraped and transferred to bacteriological grade petri
dishes in hESC media lacking FGF2, but containing 1 mM Rho-
associated protein kinase inhibitor (Y27632 or trans-4-[(1R)-1-
Aminoethyl]-N-4-pyridinylcyclohexanecar boxamide dihydrochlo-
ride; Calbiochem). On day five, EBs were plated onto matrigel
(BD) treated tissue culture plate in insulin, transferrin and selenium
(ITS) media (Dulbecco’s minimum essential medium (DMEM)/
F12, penicillin streptomycin (both from Invitrogen) and ITS
supplement (Sigma)). Medium was replenished every other day
thereafter.
For PA6 feeder differentiation, mouse PA6 stromal cells [33]
were cocultured with shKLC1-1, shKLC1-2 and unmodified
parental control hESC as described [34]. In brief, PA6 feeder
cells were plated at 6400 cells/cm
2 in growth media (high glucose
DMEM, FBS, glutamine, penicillin and streptomycin). The
following day hESC were seeded onto the PA6 feeder at a density
of 13 cells/cm
2 (for control and shKLC1-1) or 50 cells/cm
2
(shKLC1-2) in PA6 differentiation media. The medium was
exchanged on day 6 and every other day thereafter.
Neural precursor culture and viral transduction
Sorted Hues9-derived NPs were grown on polyornithine and
laminin coated plates in NP media. Medium was exchanged every
other day and cultures were split every 3–4 days. When nearly
confluent, Hues9 derived NPs were transduced with virus
containing CMV-GFP reporter cassette and U6-shKLC1 or U6-
shLUC control shRNA and centrifuged at 8006g for 45 min at
room temperature. Following expansion for 1–2 passages, cells
were subjected to fluorescence activated cell sorting to enrich for
GFP+ cells and cultured (Figure S5).
To differentiate NPs to neurons, NPs were plated on
polyornithine and laminin coated plates in NP media and grown
until they reached 70% confluence. FGF was removed and NP
media supplemented with 20 ng/ml BDNF (Peprotech), 20 ng/ml
GDNF (Peprotech) and 0.5 mM dibutyryl cAMP (N6,29-O-
Dibutyryladenosine 39,59-cyclic monophosphate sodium salt;
Sigma). Medium was exchanged every 2–3 days.
Brightfield imaging of cultures
To track morphology of the cells, cultures were imaged using a
Nikon Eclipse TS100 and a Sony Power Shot G3. The camera
was set to landscape mode, manual focus and images were
collected with 5.76zoom. A micrometer was used to calibrate the
images.
Flow cytometry
Pluripotency of undifferentiated Hues9 lines was assessed by
flow cytometric analysis of Oct3/4 and TRA-1-81. Cells were
dissociated with accutase (Invitrogen), fixed in 4% paraformal-
dehyde, permeabilized, incubated with primary antibodies
(direct conjugates from BD) and suspended to 1–2610
6 cells/
ml in sort buffer (1% FBS, 2.5 mM EDTA, 25 mM HEPES in
PBS).
Differentiated hESC cell derived neural induction cultures were
rinsed with PBS, dissociated with a 1:1 mixture of accutase and
accumax, filtered through 100 um mesh to remove cell clumps
and an aliquot counted on a hemocytometer. Antibodies (BD)
were added to a final cell concentration of 1–5610
7cells/ml.
Labeled cells were sorted at 2.5–5.0610
6 cells/ml in neural
precursor (NP) sort media (NP media - DMEM/F12, Glutamax,
B27, N2, penicillin/streptomycin (all from Invitrogen) and 20 ng/
ml bFGF (Peprotech) - supplemented with 10% FBS and 0.5 mM
EDTA). To estimate the fraction of dead cells, separate aliquots of
cells were stained with 750 nM propidium iodide, a membrane
impermeable DNA binding dye, and analyzed by flow cytometry.
Two to three percent of the cells were propidium iodide positive
regardless of the cell line or neural induction method employed.
Cells were analyzed or sorted on a BD Biosciences FACSAria
cytometer using a 100 micron diameter ceramic nozzle and 20
pounds per square inch sheath pressure. Single stained cells or
CompBeads (BD) and FACSDiva software were used to calculate
compensation values prior to analysis. Doublets were excluded
from analysis with gates on forward and side scatter bivariate plots
of pulse height relative to width (Figure S1C and Figure S2B).
Antibody positivity (Figure S1D and Figure S2B) was defined by
comparison to unstained controls. Analysis was conducted offline
using FCS Express (De Novo Software).
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Tissue culture lysates were prepared using PARIS kit (Ambion)
buffer supplemented with protease (cocktail set I, Calbiochem) and
phosphatase (Halt, Pierce) inhibitors. The BCA assay (Pierce) was
used to estimate the protein content. Equal protein amounts were
separated in MES buffer alongside Novex Sharp prestained
markers (Invitrogen) on NUPAGE 4–12% acrylamide precast gels
(Invitrogen) and then transferred to nitrocellulose (0.2 or 0.45 mm
pore size Immobilon Millipore). Membranes were blocked in 5%
BSA in tris buffered saline with 0.1% Tween-20. Primary
antibodies (KLC1 H75 1:500 Santa Cruz Biotechnology; Kine-
sin-1C 1:500 C.H. Xia (unpublished); Actin C4 1:100,000
Millipore; GFAP 1:500 Dako; NSE 1:1000 Millipore; MAP2
AP20 1:1000; a-Tubulin DM1A 1:50,000 Sigma; b-III-Tubulin
TUJ1 1:1000 Covance; phosphorylated neurofilament – heavy
and medium chains (pNF-H and pNF-M, repectively) SMI31
1:1000 Covance; Tau Tau-46.1 1:500 Millipore; pTau PHF1
1:500 Peter Davies; APP N terminus LN27 1:250 Invitrogen; APP
C terminus 1:250 Zymed/Invitrogen; 1:250 SOD1 Santa Cruz
Biotechnology; GAPDH, 1:3000 Ambion; Sox1 N23-844 1:1000,
BD; Nestin 1:1000 Millipore; GFP 11E5 1:1000 Invitrogen) were
prepared in 5% BSA. Fluorescent secondary antibodies (LiCor)
were diluted 1:6000–15,000. LiCor Odyssey infrared imager was
used to measure pixel intensities of bands at detector settings set
the maximum or one half unit below saturation. For each protein
band, background subtracted integrated intensity values were
calculated using the Odyssey software. Since absolute integrated
intensity values vary for the same samples on different blots,
samples within a blot were plotted relative to control and these
normalized values were used to average replicates from separate
blots. Linearity of antibody response was verified over the range of
1–10 mg. To show protein bands in the conventional manner with
dark bands on a light background, grayscale images were inverted
in the figures.
Immunofluorescence
Undifferentiated, shKLC1-1, shKLC1-2 and uninfected parental
control were characterized by immunofluorescence for KLC1,
Oct-4 and TRA-1–81. Cells were fixed in 4% paraformaldehyde/
0.12 M sucrose. For intracellular staining of Oct-4, KLC1, Sox1
and Nestin, cells were permeabilized with 0.1% Triton X-100,
blocked with 10% FBS in PBS, and incubated with KLC1 (H75
rabbit IgG, 1:400, Santa Cruz Biotechnology) Oct-4 (C10 mouse
IgG2b 1:300, Santa Cruz Biotechnology), Sox1 (mouse IgG
1:1000, BD Biosciences) and Nestin (rabbit IgG, 1:2000, Millipore)
primary antibodies. Secondary antibodies Alexa Fluor 568 goat
anti-rabbit IgG (H+L) or Alexa Fluor 568 goat anti-mouse IgG
(H+L) antibodies (both from Invitrogen) were used at 1:750 with
0.1 mg/ml 49,69-diamidino-2-phenylindole (DAPI; Sigma) nuclei
stain prior to mounting on slides with Prolong Gold antifade
reagent (Invitrogen). Specificity of secondary antibody staining was
verified using secondary only controls. For cell surface TRA-1-81
staining cells were fixed and blocked as above and Alexa Fluor 647
conjugated TRA-1-81 primary antibody (BD Biosciences) was
used at 1:10. Fluorescence images were collected using a Zeiss
Axioplan microscope equipped with a Zeiss Plan Neofluor 206/
0.50 NA objective, Texas Red and Cy5 filters, a CoolSNAPcf
camera (Roper Scientific) and MetaMorph (Molecular Devices)
software.
To quantify the percent of Sox1 or Nestin-positive cells in sorted
NP cultures, the Image-based Tool for Counting Nuclei (University
of California – Santa Barbara Center for Bio-Image Informatics)
plug-in of ImageJ (NIH) was used to count the number of Sox1,
Nestin and DAPI-positive cells per image. Care was taken to ensure
that the best possible input parameters were used so that the
algorithm identified cells that would also be manually judged
positive. The proportion of Sox1 and Nestin-positive nuclei was
calculated from a total of 932 DAPI nuclei. Technical replicates
were used to calculate the standard error of the mean.
Ab and soluble APP (sAPP) quantification
To measure secreted Ab and sAPP from hESC derived neural
cultures, cultures were differentiated as described and the media
changed completely 24 hours before harvest. Media was collected
and supplemented with protease inhibitors. Cells were scraped in
homogenization buffer (20 mM Tris pH 7.4, 1 mM EDTA,
1 mM EGTA, 250 mM sucrose, protease and phosphatase
inhibitors) and homogenized. Ab-40, -42 and -38 and sAPP-a
and -b were quantified in media or lysate solubilized in 1% Triton
X-100 using multiplex Meso Scale Discovery electrochemilumi-
nescence immunoassays with human specific antibodies according
to kit instructions. The data were normalized to the total protein in
the lysate. Since the fraction of neurons may differ between
cultures, we normalized the APP cleavage product to neuron-
specific enolase (NSE) lysate levels.
Results
KLC1 suppression does not alter hESC morphology or
pluripotency marker expression
To obtain undifferentiated KLC1-suppressed hESC, we
transduced Hues9 hESCs [31] with two different lentivirus [35]
coding for a KLC1-specific shRNA (referred to here as shKLC1-1
or shKLC1-2; S1A) [30]. Using limiting dilution plating single
colonies were obtained, expanded, screened by PCR for the viral
insertion and one clone of each selected for further analysis. Cell
clusters from these lines exhibited well-bordered colony morphol-
ogy typical of pluripotent stem cells (Figure 1A, arrows). Reduction
of KLC1 protein levels in undifferentiated shKLC1-1 and shKLC1-2
compared to control hESC was confirmed by both immunoflu-
orescence (Figure 1B) and immunoblot (Figure 1C).
Normal karypotypes suggest neither the subcloning process nor
KLC1 reduction caused gross cytogenetic instability (Figure S1B).
Fluorescence micrographs of Octamer-4 (Oct-4) and Tumor
Rejection Antigen 1–81(TRA-1-81) revealed similar cellular
distributions of Oct-4 in the nucleus (Figure 1D) and TRA-1-81
on the cell surface (Figure 1E) of control and KLC1 depleted cells
suggesting depletion of KLC1 has no obvious effect on localization
of these two pluripotency markers. Using flow cytometry, we
found similar proportions of shKLC1-1, shKLC1-2 and control cells
expressing both Oct4 and TRA-1-81 (Figure 1F). From these data
we suggest that undifferentiated pluripotent cells with 70–80%
reduced KLC1 exhibit apparently normal colony morphology,
karypotypes and pluripotency marker expression.
KLC1-suppressed human neural cells exhibit shorter
neurites
Several lines of evidence suggest that neurons with impaired
Kinesin-1 subunits may be smaller. KLC1 mutant mice have
reduced white matter in the brain and spinal cord [11], Kinesin-
1C mutant mice have smaller brains [9] and various dysfunctional
Kinesin-1 subunits leads to reduced neurite lengths [12–14,36,37].
We tested whether human neurons with depleted KLC1 were
similarly impaired. The PA6 feeder method has been shown to
generate mature neuronal cultures [34], so we used it to generate
and compare control and KLC1-suppressed mature neural
cultures by differentiating hESC in vitro for seven weeks. We
examined the morphology over time of control, shKLC1-1 and
Neural Differentiation of KLC1-Suppressed hESC
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imaging. By in vitro differentiation day nine, hESC derived cell
clusters peppered the feeder cell monolayer (Figure 2A, left
panels). Since human neural differentiation from hESC generally
follows human embryonic developmental principles [38], we
observed differentiation cultures eighteen days from the undiffer-
entiated hESC state, during the developmental equivalent of the
neural tube stage. At this stage, control, shKLC1-1 and shKLC1-2
hESC derived day cultures contained ‘rosette’ cell cluster
structures (Figure 2A arrows and insets) which resemble the
Figure 1. Undifferentiated KLC1-suppressed hESC exhibit normal morphology, pluripotency marker expression and karyotypes. (A)
Representative images of control, shKLC1-1 and shKLC1-2 undifferentiated hESC cultures showing bordered colony morphology typical of pluripotent
cells (arrows). Scale bar 200 micrometers. (B) Immunofluorescence staining of KLC1 in undifferentiated hESC control, shKLC1-1 and shKLC1-2 colonies.
Merged images show overlay of KLC1 (red) and DAPI-stained nuclei (blue). Scale bar 50 micrometers. (C) Equal protein from undifferentiated control,
shKLC1-1 and shKLC-2 culture lysates were analyzed by Western blot for KLC1 and Actin. Bar graph shows Actin normalized KLC1 levels relative to
control. n=3; **p,0.01, ***p,0.001 by 2-tailed t-test compared to control. (D–E) Immunofluorescence imagesof undifferentiated control, shKLC1-1
and shKLC1-2 cultures for pluripotency markers Oct-4 (D) and TRA-1-81 (E). Merged images show overlay of Oct-4 (D; red) or TRA-1-81 (E; red) and
DAPI-stained nuclei (blue). Scale bar 50 micrometers. (F) Bivariate plots show distribution of cells in control, shKLC1-1 and shKLC1-2 undifferentiated
cultures Oct-4+TRA-1-81+ (in blue). Data is representative of three experiments.
doi:10.1371/journal.pone.0029755.g001
Neural Differentiation of KLC1-Suppressed hESC
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29755neural tube and are typically found in neural induction cultures
[38], suggesting the cultures may contain NP cells. By differen-
tiation day twenty-two these hESC-derived cell clusters had
sprouted axon-like projections, which persisted at least until
differentiation week seven (compare right-most two panels of
Figure 2A). While all lines followed this differentiation progression,
shKLC1-1 and especially shKLC1-2 appeared to exhibit reduced cell
cluster size and overall cell density over the course of the
differentiation (Figure 2A and Figure S2) and less extensive and
shorter projections in polarized cells at the time of harvest
(Figure 2A, arrows in right-most panel and Figure S2). We
wondered if the severity of phenotype correlated with KLC1
knockdown efficiency. Therefore, we used Western blotting to
assess KLC1 protein levels in culture lysates from differentiated
Figure 2. KLC1 and Kinesin-1C subunits are reduced in neural cultures derived from KLC1-suppressed hESC. (A) Control, shKLC1-1 and
shKLC1-2 hESC were differentiated for seven weeks using the PA6 feeder method. Representative bright field images of control, shKLC1-1 and shKLC1-
2 PA6 feeder cocultures collected at nine, eighteen, twenty-two and forty-eight days after plating. Arrows point to rosettes. Insets show close-ups of
indicated rosettes. Arrowheads denote axon-like projections emanating from hESC derived cell clusters. Scale bars: 200 mm for main images, 50 mm
for insets. (B) PA6 neural differentiation cultures were harvested after seven weeks in vitro and equal protein from control, shKLC1-1 and shKLC1-2
cultures analyzed by Western blotting for KLC1, Kinesin-1C and Actin. Bar graphs show relative quantification of KLC1 and Kinesin-1C levels relativet o
Actin. Based on n=7 control and shKLC1-1;n=3shKLC1-2, ***p,0.001 by two-tailed Student’s t-test compared to control.
doi:10.1371/journal.pone.0029755.g002
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levels in shKLC1-1 and shKLC1-2 were reduced to 46% and 2% of
control levels, respectively (Figure 2B), suggesting that knockdown
is maintained for at least seven weeks of PA6 feeder differentiation.
Previous experiments in D. melanogaster and M. musculus suggested
that genetic reductions in KLC can lead to reduction in KHC and
vice versa (unpublished data). We extended these observations to
human neural cultures and found reduced Kinesin-1C in KLC1-
suppressed differentiation cultures - to 47% and 20% of control
(Figure 2B). These data indicated to us that reduced levels of
KLC1 and/or Kinesin-1C may impair neural differentiation in a
dose dependent fashion.
KLC1-suppressed human neural cells have reduced levels
of microtubule-associated proteins and altered APP
metabolism
To discover if KLC1 suppression has gross affects on the cellular
composition of the PA6 differentiation cultures incubated for seven
weeks, we used Western blotting to survey a panel of species-
specific and neuronally enriched markers. Because of limited
shKLC1-2 material we were focused our analysis on the control and
shKLC1-1 lines. Since mouse PA6 feeder cells may linger in hESC
differentiation cultures, we first assessed the relative contribution
of these feeder cells by comparing levels of ‘‘housekeeping’’
proteins Actin, Glyceraldehyde 3-Phosphate Dehydrogenase
(GAPDH) and Superoxide Dismutase (SOD1) in PA6 feeder cells
cultured for seven weeks in the presence or absence of control or
shKLC1-1 hESC. Mouse and human SOD1 and GAPDH proteins
have different electrophoretic mobilities so the presence or absence
of the mouse and human bands can indicate the contribution of
mouse PA6 cell derived compared to human protein. The mouse
SOD1 and GAPDH bands were easily detectable in PA6 feeder
cell lysates, but not in samples derived from PA6 cells cocultured
with either control or shKLC1-1 hESC (Figure 3A), implying to us
minimal PA6 mouse cell contamination within the differentiation
cultures.
Figure 3. Neural cultures derived from KLC1-suppressed hESC have reduced neural microtubule-associated markers. (A) Cultures
were harvested at seven weeks in vitro and equal protein from mouse PA6 feeders cultured with control, shKLC1-1 or no hESC (PA6 feeder cells lane)
were analyzed by Western blotting for actin, GAPDH and SOD1. Note that unlike Actin, mouse and human GAPDH and SOD1 have different
electrophoretic mobilities (arrows). (B–C) Control or shKLC1-1 hESC were cultured for seven weeks with PA6 feeder cells and then harvested. Equal
protein from control and shKLC1-1 cultures was analyzed by Western blotting. (B) Representative immunoblots of Actin, NSE, GFAP, a-Tubulin, b-III-
Tubulin, MAP2, pNF-H, pNF-M, Tau and pTau. (C) Quantification of protein levels relative to control and normalized to Actin. Based on n=6 wells each
*p,0.05, **p,0.01, ***p,0.001 by 2 tailed t-test compared to control.
doi:10.1371/journal.pone.0029755.g003
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control and shKLC1-1 seven week PA6 feeder differentiation
cultures by assessing relative levels of neuron marker Neuron
Specific Enolase (NSE) and glial marker Glial Fibrillary Acidic
Protein (GFAP) by Western blot. Since these cultures also likely
contained other hESC differentiation progeny, we used the
ubiquitously expressed protein Actin as a normalizer. Although
on average there appeared to be less relative NSE and GFAP
protein in shKLC1-1 compared to control differentiation cultures,
this trend did not reach statistical significance (p=0.13 and
p=0.10, respectively; Figure 3B–C), indicating that the propor-
tions of neurons and glia within control and shKLC1-1 PA6
differentiation cultures were not different.
Our imaging data led to us propose that human neuron-like cells
produced in PA6 differentiation cultures from hESC with reduced
KLC1 may have shorter projections than control cells (Figure 2A
right-most panel and Figure S2). To test whether KLC1-suppressed
hESC produce neuron-like cells with normal proportions of the
microtubulecomponentsenriched inneurites, wecompared levels of
Actin normalized a-Tubulin, b-III-Tubulin, the dendrite marker
microtubule-associated protein 2 (MAP2) and axonal markers (pNF;
heavy –pNF-H and medium - pNF-M chains) and full length Tau
(using both phosphorylation-dependent and -independent antibod-
ies). Interestingly, shKLC1-1 compared to control differentiation
cultures had 25–30% less microtubule subunits a-Tubulin and b-III-
Tubulin (an isoform enriched in neurons) and MAP2 (Figure 3B–C).
Axonal markers pNF-H and pNF-M were also reduced by 25–35%
while Tau was down by .60%, regardless of phosphorylation state
(Figure 3B–C). These observations suggest that while pluripotent
cellswithreducedKLC1arecapableofdifferentiationtoneuron-like
progeny,the processis lessefficient,producing feweroverall progeny
and neurons with shorter projections and less MT-associated
cytoskeletal components. Because APP metabolism is linked to
AD, it is important to understand how it is regulated in human
neurons at endogenouslevels.APP associatescloselywith KLC1and
its axonal transport is Kinesin-1 dependent [20–23]. Reduction of
full length murine KLC1 in adult mice expressing transgenic human
familial AD-associated APP perturbs brain Ab levels [26]. Ab is
produced by the sequential cleavage of APP by b-secretase and then
c-secretase, while APP cleavage by the a-secretase prevents
formation of Ab peptides (Figure 4A). To assess whether human
KLC1 depletion alters APP metabolism in human neural cultures,
we measured levels of full length APP and its extracellular
metabolites in control or shKLC1-1 hESC PA6 differentiation
cultures aged seven weeks. To account for possible differences in the
fraction of neurons between cultures we normalized the values to
NSE. While levels of full length APP (Figure 4B–C) or soluble
intracellular Ab (Figure 4E) in control compared to shKLC1-1 PA6
feeder cultures were not significantly different, secreted extracellular
Ab levels were substantially reduced in KLC1-suppressed neural
cultures (Figure 4D). Regardless of KLC1 levels, 99% of the Ab40
detected was found in the extracellular fraction. We also tested if
PA6 differentiation cultures derived from shKLC1-1 compared to
control hESC have similar levels of extracellular sAPPb or sAPPa
fragments.Wediscovered thatKLC1depletion didnotalterlevelsof
sAPPa, but KLC1 depleted neural cultures had less extracellular
sAPPb than control (Figure 4F). These results suggest that KLC1
suppression in human neurons may perturb APPb,b u tn o tA P P a
cleavage of endogenous APP.
Neural precursors with reduced KLC1 do not proliferate
normally
To gain insight into why neuronal cultures derived from hESC
with reduced KLC1 are less dense and have reduced microtubule-
associated proteins and APP processing, we examined NPs, the
cells that divide and give rise to neurons and glia. Flow cytometry
is a useful tool for identifying stem cell populations [39] and we
have recently developed a flow cytometry-based method to
identify and sort out NPs derived from either PA6 feeder
differentiation or an alternative neural differentiation method in
which nonadherent floating cell clusters, called EBs, are generated
and plated on in neuralizing media (Figure S3A) [32]. To
determine which method gives the best NP yield, we used both to
generate NPs from control hESC. Like the PA6 method, the EB
method generated rosette cell clusters (Figure 5A; compare to
Figure 2A). Flow cytometric analysis of progeny exhibiting high
levels of CD184 and CD24 and low levels of CD271 and CD44, a
cell surface signature characteristic of cells which differentiate into
neurons and glia (CD184
hiCD24
hiCD271
loCD44
lo) [32], revealed
that the EB method generated more than four times more
CD184
hiCD24
hiCD271
loCD44
lo NPs than the PA6 method
(Figure 5B and Figure S3B–C). Therefore, we used the more
efficient EB method to ask how reduced KLC1 affects production
of CD184
hiCD24
hiCD271
loCD44
lo NPs. Similar to the trend
observed with PA6 feeder cultures (Figure 2A), EB neural
induction cultures from hESC with reduced KLC1 appeared to
have fewer and smaller overall colonies (Figure S4A), suggesting
reduced overall cell densities compared to control. We confirmed
this observation by quantifying day eighteen control, shKLC1-1
and shKLC1-2 neural induction culture cell densities which
revealed that KLC1 suppression lowers overall cell densities in a
KLC1 dose dependent fashion (Figure 5C). To learn whether
KLC1 suppression alters the proportion of NPs within the cultures
we used flow cytometry to quantify the percent of control, shKLC1-
1 and shKLC1-2 PA6 feeder and EB neural induction culture cells
with the CD184
hiCD24
hiCD271
loCD44
lo NP signature. PA6
feeder derived shKLC1 neural induction cultures had normal
proportions of NPs (Figure S4B). Interestingly, EB neural
induction cultures derived from KLC1-suppressed hESC had
,50% reduced fraction of CD184
hiCD24
hiCD271
loCD44
lo cells
(Figure 5D and Figure S3B), suggesting that reduction in KLC1 in
hESC can lead to lower NP proportions that could reduce
differentiation culture cell densities.
To address whether KLC1 levels affect NP function, we sorted
NPs from EB neural induction cultures derived from hESC with
normal or reduced KLC1. Regardless of KLC1 levels, sorted NP
cells appeared morphologically similar initially (Figure 6A).
However NP cells with reduced KLC1 failed to multiply while
NP cells differentiated from control hESC proliferated, expressed
NP markers Sox1 and Nestin (Figure 6B–C and Figure 6D, control
lane) and differentiated to cultures containing highly polarized
cells resembling neurons (Figure 6E) and containing neuronal
markers (Figure 6F, control lane). Since sorted NP cells expressing
shRNA to KLC1 did not proliferate we were unable to assess their
NP marker expression or neuronal differentiation potential by
Western blot.
To confirm that KLC1 suppression prevents normal NP
propagation in homogeneous NP cultures, we transduced control
hESC derived EB NP cells with lentivirus containing a GFP
reporter and either shRNA to KLC1 (shKLC1) or a control
luciferase shRNA (shLUC) and sorted GFP positive cells (Figure
S5). Like uninfected control NP cells, GFP positive shLUC NP
cells proliferated, expressed NP markers Sox1 and Nestin
(Figure 6D, shLUC lane) and differentiated to cultures containing
neuron markers (Figure 6F, shLUC lane). In contrast, GFP sorted
shKLC1 lentivirus infected NPs did not proliferate and thus we
could not assess their differentiation potential. Taken together we
conclude that cellular defects induced by KLC1 suppression can
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hiCD24-
hiCD271
loCD44
lo NP populations, leading to reduced overall
neural differentiation culture densities.
Discussion
KLC1 suppression affects microtubule associated
proteins
Since KLC1 mutant animals exhibit neural defects, we tested
whether reduced KLC1 impairs the differentiation of hESC to
neural cells. We found that the neural microtubule-associated
markers b-III-Tubulin, MAP2, pNF and Tau are reduced in
KLC1 suppressed compared to control cultures. Intriguingly,
previous studies suggest that Kinesin-1 may transport Tubulin,
thereby regulating cell size and shape [13,40,41]. If KLC1
reduction impairs transport of microtubules into neuronal
projections, it may cause reductions in cell size, neurite length
and levels of microtubule-associated proteins such as MAP2, pNF
and Tau. Indeed several studies report reductions in neurite length
in KHC or KLC-depleted cultured rodent hippocampal neurons
[12–14] and in the dendrites of neurons in C. elegans and D.
melanogaster [36,37]. Reductions in cell size may also partially
account for body size reductions observed in Kinesin-1 mutant
flies and mice and the reduced white matter tracts observed in the
KLC1 mutant mouse [11,15–17]. Alternatively, reduced levels of
neural microtubule-associated proteins in the KLC1 suppressed
Figure 4. Human neural cultures with reduced KLC1 exhibit altered APP metabolism. (A) APP proteolytic processing by either b-and c-
secretases or a- and c-secretases produces sAPPb and Ab (shaded dark grey) or sAPPa and p3 fragments, respectively. (B–C) PA6 feeder neural
differentiation cultures were harvested after seven weeks and equal protein from control and shKLC1-1 cultures were analyzed using Western blots.
(B) Representative immunoblots for full length APP in control and shKLC1-1 neural differentiation lysates. Results for both amino (APP-N; LN27) and
carboxy terminal (APP-C) antibodies are shown. The APP carboxyl terminal cleavage fragments were not reliably detected. (C) Quantification of full
length APP levels relative to NSE. (D) Levels of extracellular human Ab peptides 38, 40 or 42 amino acids in length detected in media conditioned by
control or shKLC1-1 hESC co-cultured with PA6 feeder cells for seven weeks. Human Ab was not detected from PA6 feeder only cultures. (E) Levels of
Triton X-100 soluble intracellular human Ab-40 in control or shKLC1-1 PA6 feeder differentiation cultures aged seven weeks. Intracellular Ab peptides
38 or 42 amino acids long were not detectable. (F) Levels of human extracellular sAPPa and sAPPb were detected in media conditioned by control or
shKLC1-1 PA6 feeder cocultures aged in vitro for seven weeks. Based on n=6 each line; *p,0.05, **p,0.01 by 2-tailed t-test.
doi:10.1371/journal.pone.0029755.g004
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fewer NPs although neither NSE levels nor the fraction of
neuronal (b-III isoform as a fraction of the more widely expressed
a-Tubulin) Tubulin were different in neural cultures derived from
hESC with normal or KLC1-depleted hESC.
Effect of KLC1 suppression on APP metabolism in human
neural cultures
We found that neural cultures derived from KLC1-reduced
hESC have less Ab compared to control, supporting a functional
connection between KLC1 and APP trafficking and/or metabo-
lism. The exact nature of this connection is unknown. However,
evidence suggests that Kinesin-1 may transport APP within axons
of neurons [21,26,42]. The intracellular location of APP is thought
to affect its metabolism with a-secretase cleavage likely occurring
at the plasma membrane and b-secretase cleavage in endosomal
compartments [43]. Once produced, sAPP and Ab peptides are
secreted [44] and Ab may be degraded by proteases, such as
Neprilysin, in the extracellular milieu [45]. Kinesin-1 based axonal
transport defects could disrupt any or all of these processes. Our
data imply no net effect on extracellular levels of sAPPa in neural
cultures derived from hESC with depleted compared to control
KLC1 levels, suggesting this cleavage pathway may be normal.
However, extracellular levels of b-cleavage pathway products
sAPPb and Ab are both reduced in the KLC1-suppressed
compared to control hESC derived neural cultures, suggesting
the APPb cleavage pathway is disrupted by impaired KLC1. The
reduced extracellular Ab from KLC1-reduced hESC derived
human neural cultures agrees with reports of reduced amyloid
plaque loads following mechanical disruptions in axonal transport
in the perforant pathway of APP transgenic mice [46].
Experiments in better defined human neural cultures will be a
first step to understanding the nature of this effect in human
neurons.
Work in transgenic mice expressing a familial AD mutant APP
suggests that axonal transport perturbations arising from reduced
KLC1 function lead to earlier and increased brain Ab production
and plaque deposits [26]. Compared to mice with normal Kinesin-
Figure 5. Neural induction cultures made from KLC1-suppressed hESC have reduced cell densities and proportions of NPs. (A–D)
Control, hESC were subjected to neural induction conditions for eighteen days using PA6 feeder or EB methods as indicated. (A) Bright field image of
control EB neural induction culture (see Figure 2A for image of PA6 differentiation). Arrows point to rosettes. Insets show close-ups of indicated
rosettes. Scale bars: 200 mm for main images, 50 mm for insets. (B) Percent of cells in control EB and control PA6 feeder differentiation cultures with
CD184
hiCD24
hiCD44
loCD271
lo NP cell surface marker signature (C) Quantification of cell density in EB control, shKLC1-1 and shKLC1-2 hESC EB neural
induction cultures. EB cultures were dissociated enzymatically and counted using a hemocytometer. (D). Percent of cells within EB control, shKLC1-1
and shKLC1-2 hESC differentiation cultures exhibiting CD184
hiCD24
hiCD44
loCD271
lo NP cell surface marker signature after. For (B–C), control n=9,
shKLC1-1 n=6,shKLC1-2 n=3. For (D), n=3 each line. **p,0.01, ***p,0.001 by 2-tailed t-test compared to control.
doi:10.1371/journal.pone.0029755.g005
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PLoS ONE | www.plosone.org 9 January 2012 | Volume 7 | Issue 1 | e29755Figure 6. Sorted control but not KLC1-suppressed NPs proliferate and differentiate to neurons. (A) Cells exhibiting the NP cell surface
signature were sorted by flow cytometry. Representative images of EB derived NP bright field morphology one day post-sort. Arrows point to
individual cells with similar morphology. Scale bar 100 mm. (B) Immunofluorescence for NP intracellular markers Sox1 and Nestin in sorted NP cells
from control hESC cultures generated using the EB method. Merged image shows overlay of Sox1 (red), Nestin (green) and DAPI stained nuclei (blue).
(C) Quantification of percent of cells (=DAPI nuclei) positive for Sox1 or Nestin in control derived NP cells. (D) Hues9 derived NPs sorted from EB
neural induction cultures were infected with virus containing expression cassettes for a GFP selection marker and shRNA targeting luciferase (shLUC),
which is not normally expressed in these cells. Western blotting was used to verify expression of NP markers Nestin and Sox1 in shLUC compared to
uninfected control NPs. Also shown are the loading control Actin and the GFP selection marker. (E) Representative bright field image of control hESC
derived NPs differentiated for a further 10 weeks. Arrowheads show neurites extending from cell clusters. Scale bar 100 mm. (F) Hues9 derived control
or shLUC infected EB derived and flow sorted NPs were differentiated to neurons for five weeks and equal amounts of protein analyzed by Western
blotting for a-Tubulin, neuronal markers b-III-Tubulin, MAP2 and Tau as well as an Actin loading control and GFP selection marker.
doi:10.1371/journal.pone.0029755.g006
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neural tissues [11,25]. Here we find that human KLC1 depletion
in hESC-derived neural cultures reduces endogenous levels of Tau
and Ab. It is unclear why KLC1 disruption in human neural
cultures reduces Ab and Tau while in mouse brain, these proteins
are increased. Possible explanations include species specific
differences, modes of KLC1 perturbation, neuron type or maturity
or differences in production or turnover. Nonetheless, together our
data support functional connections between KLC1 and levels of
Tau and Ab.
A role for the KLC1 subunit of Kinesin-1 in NP
maintenance?
Previous studies suggest important functions for Kinesin-1
subunits in the development and maintenance of the nervous
system. For example, expression patterns of Kinesin-1 subunits
reveal that Kinesin-1A, Kinesin-1B, Kinesin-1C, KLC1 and
KLC2 are widely expressed in neural tissues [7–10]. In fact,
mouse neurons lacking full length Kinesin-1A, Kinesin-1B,
Kinesin-1C or KLC1, or Drosophila neurons lacking KHC or
KLC, exhibit moderate to severe defects in axonal transport and
other neuronal phenotypes [9,10,15,17,18]. Previous studies in
our lab showed that KLC1 reduction in mice leads to altered
localization and phosphorylation of Tau while KLC1 heterozy-
gous animals also expressing a human APP transgene exhibit
increased brain Ab, two phenotypes associated with AD
[11,25,26]. Other work documenting the absence of significant
phenotypes caused by loss of Kinesin-1 subunits in virtually all
non-neuronal cell types suggest that Kinesin-1, and KLC 1 in
particular, does not have ‘‘housekeeping’’ functions [15,47,48].
Our finding that KLC1-suppressed hESC do not have growth or
other obvious phenotypes is consistent with these previous
studies. However, previous findings that Kinesin-1C mutant
mice have smaller brains and that KLC1 mutant mice have
smaller bodies and reduced white matter compared to wildtype
raise the possibility of cell proliferation defects during nervous
system development [9,11,15]. Therefore, we tested for NP
defects in human neural induction cultures with perturbed
KLC1. Since over-expression of KLC1 leads to non-physiological
cellular aggregation of the protein which is difficult to interpret,
we tested the effect of reduced endogenous KLC1 [14,49]. We
found neural induction cultures derived from KLC1-suppressed
compared to control hESC have reduced overall cell densities.
Our data also show that both NPs sorted from KLC1-suppressed
hESC neural induction cultures and sorted control NPs infected
with lentivurus coding for shRNA to KLC1 fail to proliferate.
These data suggest the hypothesis that KLC1 reduction impairs
NP proliferation capacity. Given the neural expression of other
Kinesin-1 subunits and the growth retardation defects observed
in Kinesin-1A, Kinesin-1B and Kinesin-1C mutant mice, it is
possible these other subunits may also have important functions
in NP maintenance.
Supporting Information
Figure S1 Lentiviral modification, karyotypes and flow
cytometric analysis gating strategies for undifferentiat-
ed hESC. (A) Diagram of shRNA constructs used to produce cells
with reduced KLC1. The sequences for reverse and forward DNA
oligonucleotides with KLC1 exon 2 targeted sequences were:
Forward 59-TGTAATTTGGTGGAGGAGAATTCAAGAGA-
TTCTCCTCCACCAAATTACTTTTTTC-39 and Reverse 59-
TCGAGAAAAAAGTAATTTGGTGGAGGAGAATCTCTT-
GAATTCTCCTCCACCAAATTACA -39 (B) Metaphase chro-
mosome spreads of Hues9 passage 41: 46,XX,inv(9)(p12q13),
shKLC1-1 passage 42: 46,XX,inv(9) and shKLC1-2 passage 44:
46,XX,inv(9)(p12q13). (C) Hues9 percentile contour plots showing
gating strategy to exclude coincident events. (DC) Representative
Hues9 percentile contour plots showing gating for pluripotency
markers TRA-1-81 and Oct-4. (E) Gating hierarchy for events.
(TIF)
Figure S2 Morphology of neural cultures derived from
control and KLC1 suppressed hESC. Control, shKLC1-1
and shKLC1-1 hESC were differentiated for seven weeks using the
PA6 feeder method. Bright field images show control, shKLC1-1
and shKLC1-2 PA6 feeder cocultures at seven weeks since plating.
Scale bar=200 mm.
(TIF)
Figure S3 Neural induction and neural precursor flow
cytometry gating strategies. (A) Timeline of events for PA6
feeder and EB neural induction cultures. (B) Hues9 control
percentile contour plots showing scatter gates for excluding
coincident events (top panels) and for both positive (CD184 and
CD24) and negative (CD44 and CD271) NP cell markers (bottom
panels). Gating hierarchy shown below contour plots. (C) Back-
gating of CD184
hi CD24
hi CD271
lo CD44
lo population (shown in
blue) on CD184 – CD44 & CD271 bivariate dot plots for control,
shKLC1-1 and shKLC1-2 PA6 feeder and EB neural induction
cultures 18 days in vitro.
(TIF)
Figure S4 Additional properties of neural induction
cultures. (A) Control, shKLC1-1 and shKLC1-2 hESC were
subjected to neural induction conditions for eighteen days
using the EB method. Bright field images of neural induction
cultures eighteen days in vitro. Arrowheads point to rosettes.
Insets show close-ups of indicated rosettes. Scale bars: 200 mm
for main images, 50 mm for insets. Note the control image is
also shown in Figure 6A and is reproduced here for ease in
comparison. (B) Percent of cells within PA6 feeder control,
shKLC1-1 and shKLC1-2 hESC derived neural induction
cultures exhibiting CD184
hiCD24
hiCD44
loCD271
lo NP cell
surface marker signature.
(TIF)
Figure S5 Scheme for infection and sorting of NPs with
lentivirus expressing shRNA to KLC1 or Luciferase. (A) A
lentiviral vector encoding a GFP expression cassette and either a
shRNA targeted to KLC1 (shKLC1) or Luciferase (shLUC) is
packaged into virus. (B) Dissociated Hues9 derived NP cells are
exposed these virion, (C) GFP positive cells sorted by flow
cytometry and (D) plated for expansion.
(TIF)
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